YI - 111, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
6.70
-0.07 (-1.03%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close6.77
Open6.90
Bid6.80 x 800
Ask6.81 x 1200
Day's Range6.51 - 6.94
52 Week Range2.29 - 9.20
Volume63,786
Avg. Volume390,272
Market Cap549.802M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.27
Earnings DateMay 13, 2020 - May 17, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est85.32
  • 111 and Wenjiang People's Hospital to Build Online Cancer Diagnosis and Treatment Platform
    PR Newswire

    111 and Wenjiang People's Hospital to Build Online Cancer Diagnosis and Treatment Platform

    China's leading online pharmaceutical network and healthcare service provider is partnering with the Wenjiang People's Hospital in Chengdu to build an online cancer diagnosis and treatment platform for rare tumors using imported drugs. The new rare tumor platform will be linked with the national network of online diagnosis and treatment services operated by 111, Inc. (NASDAQ: YI) ("111"), which is creating a healthcare ecology around medical consultations as well as prescription drug supply through its partnerships with 235,000 out of China's 450,000 pharmacies.

  • 111 Launches Free Consultation Services for Chinese Citizens Abroad against COVID-19
    PR Newswire

    111 Launches Free Consultation Services for Chinese Citizens Abroad against COVID-19

    111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform in China, announced today that it has started to offer free online consultation service to Chinese nationals living and working abroad through its Internet hospital since March 17. This expands the Company's pioneering efforts to combat the outbreak, by providing including free online consultations to the large numbers of Chinese living, working, or visiting overseas.

  • Analysts Expect Breakeven For 111, Inc. (NASDAQ:YI)
    Simply Wall St.

    Analysts Expect Breakeven For 111, Inc. (NASDAQ:YI)

    111, Inc.'s (NASDAQ:YI): 111, Inc., through its subsidiaries, operates an integrated online and offline platform in the...

  • 111, Inc. Announces Fourth Quarter and Fiscal Year 2019 Unaudited Financial Results
    PR Newswire

    111, Inc. Announces Fourth Quarter and Fiscal Year 2019 Unaudited Financial Results

    111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2019.

  • Emergency Service from 111 Helps Companies Secure Epidemic Supplies to Open for Business
    PR Newswire

    Emergency Service from 111 Helps Companies Secure Epidemic Supplies to Open for Business

    Businesses across China need to secure epidemic supplies such as face masks and disinfectant to re-open factories and offices. Now they will be able to turn to 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform. 111 announced its "Medical Supply Assurance Service" today, which enables business owners to use 111's online platforms to submit applications for protective materials against COVID-19 contagion as well as free online consultations, prescription refills, and customized healthcare service packages.

  • 111 to Announce Fourth Quarter and Fiscal Year 2019 Unaudited Financial Results on March 12, 2020
    PR Newswire

    111 to Announce Fourth Quarter and Fiscal Year 2019 Unaudited Financial Results on March 12, 2020

    111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2019 ended December 31, 2019, before the open of U.S. markets on Thursday, March 12, 2020.

  • 111 Partners with Financial Institutions in Battle Against Coronavirus
    PR Newswire

    111 Partners with Financial Institutions in Battle Against Coronavirus

    111, Inc. (NASDAQ: YI, "111" or the "Company") has announced that it will leverage its knowhow and technology in the battle against the novel coronavirus (COVID-19) public health crisis, through partnerships with some of China's leading financial institutions to distribute medical services via apps to their extensive consumer bases. Currently 111's partnerships with the Industrial and Commercial Bank of China, UnionPay QuickPass, Shanghai Pudong Development Bank, Wuhan Zhongbang Bank, Yiren Wealth, among others, are providing free online medical consultations. 111's partnership with the Industrial and Commercial Bank of China is a pilot program aiming to provide online consultation to 13 million users in Shanghai.

  • 111 Partners with Winhealth to Offer "Free Refill + End-to-End Delivery" Services to Patients with Chronic Diseases
    PR Newswire

    111 Partners with Winhealth to Offer "Free Refill + End-to-End Delivery" Services to Patients with Chronic Diseases

    As the novel coronavirus epidemic continues to evolve in China, the country has introduced controls to prevent the spread of the epidemic and reduce the risk of contagion. Among the measures adopted is home quarantine, which has created challenges for patients with chronic diseases requiring visits to hospitals or clinics to obtain refills for their medications.

  • 111 Inc. Offers Free Online Consultation and Prescription Refill Services
    PR Newswire

    111 Inc. Offers Free Online Consultation and Prescription Refill Services

    In response to the evolving global epidemic created by the outbreak of 2019-nCOV coronavirus, 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, is providing a series of services and charity donations to help those affected.

  • 111 Unveils New Video on The Impact of Chinese Policies to Medical Industry
    PR Newswire

    111 Unveils New Video on The Impact of Chinese Policies to Medical Industry

    111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced the release of the sixth episode in its 111 Insight series. The title announced today, The Impact of Chinese Policies to Medical Industry, is hosted by Dr. Gang Yu, Co-Founder and Executive Chairman of 111, Inc. Dr. Yu will moderate a discussion with Dr. Xiaobin Wu, President of BeiGene Ltd, and Dr. Darren Ji, CEO of Elpiscience Biopharma, Ltd.

  • 111 Unveils New Video on the Impact of the Internet and other New Technologies on the Medical Industry
    PR Newswire

    111 Unveils New Video on the Impact of the Internet and other New Technologies on the Medical Industry

    111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced the release of the fifth episode in its 111 Insight series. The title announced today, The Impact of the Internet and Other New Technologies on the Medical Industry, is hosted by Dr. Gang Yu, Co-Founder and Executive Chairman of 111, Inc. Dr. Yu will moderate a discussion with Dr. Xiaobin Wu, President of BeiGene Ltd, and Dr. Darren Ji, CEO of Elpiscience Biopharma, Ltd.

  • 111, Inc. Featured at 38th Annual JP Morgan Healthcare Conference
    PR Newswire

    111, Inc. Featured at 38th Annual JP Morgan Healthcare Conference

    Junling Liu, co-founder, Chairman, and Chief Executive Officer of 111, Inc. (NASDAQ: YI) a leading integrated online and offline healthcare platform, gave an address entitled "Driving Transformation in China's Healthcare and Pharmaceutical Industry" at the 38th Annual JP Morgan Healthcare Conference (the "Conference").

  • 111, Inc. Enters Into Strategic Partnership with Bestyoo to Upgrade Online Healthcare Service Model
    PR Newswire

    111, Inc. Enters Into Strategic Partnership with Bestyoo to Upgrade Online Healthcare Service Model

    111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced that it has entered into a strategic partnership with Bestyoo, a prescription information sharing solutions provider in China. 111 will work with Bestyoo's third-party online prescription information transferring and sharing platform (the "Platform") to provide its users with prescription-based online drug purchase and home delivery services. Bestyoo and 111 will also jointly provide online consultation services to patients. This strategic partnership is expected to create a more standardized and feasible process for prescription information sharing and online sales of prescription drugs, bringing easy-to-access healthcare services to more patients in China.

  • Introducing 111 (NASDAQ:YI), The Stock That Dropped 36% In The Last Year
    Simply Wall St.

    Introducing 111 (NASDAQ:YI), The Stock That Dropped 36% In The Last Year

    111, Inc. (NASDAQ:YI) shareholders should be happy to see the share price up 22% in the last quarter. But that doesn't...

  • 111 Inc to Attend the JP Morgan 2020 Healthcare Conference in San Francisco, January 14-15, 2020
    PR Newswire

    111 Inc to Attend the JP Morgan 2020 Healthcare Conference in San Francisco, January 14-15, 2020

    111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that the Company will attend the JP Morgan 2020 Healthcare Conference in San Francisco, CA, USA, January 14-15, 2020 and meet with institutional investors.

  • 111 Named "National High-tech Enterprise" by the Government
    PR Newswire

    111 Named "National High-tech Enterprise" by the Government

    China's Ministry of Science and Technology has named 111, Inc. (NASDAQ: YI) ("111" or the "Company") a "National High-tech Enterprise", the Company announced today. The designation is one of the highest awards for Chinese technology companies and makes 111 eligible for government benefits as a strategic high-technology company. The designation is also a recognition of 111's depth of talent, technological expertise, and innovative role in China's pharmaceutical and healthcare sector.

  • 111 Inc. Hosts 2019 Online Pharmaceuticals and Healthcare Summit
    PR Newswire

    111 Inc. Hosts 2019 Online Pharmaceuticals and Healthcare Summit

    111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, convened the China Online Pharmaceuticals and Healthcare Summit 2019 (the "Summit") together with its annual general suppliers' meeting in Shanghai on December 11. The event, themed, "Technology Empowerment and Mutually Beneficial Cooperation", focused on the implications for the industry as China scales up its centralized drug procurement policy from the initial "4+7" pilot cities (the "4+7" Policy) expanding to more provinces and regions, as well as ways to empower the pharmaceutical industry with Internet technology in both R&D; and distribution.

  • Here is What Hedge Funds Think About 111, Inc. (YI)
    Insider Monkey

    Here is What Hedge Funds Think About 111, Inc. (YI)

    Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]

  • PR Newswire

    111, Inc. Announces Third Quarter 2019 Unaudited Financial Results

    SHANGHAI , Nov. 14, 2019 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China , today announced its ...

  • PR Newswire

    111 Signs Strategic Partnership with HEC Group to Strengthen Cooperation with Innovative Pharmaceutical Manufacturer

    SHANGHAI , Nov. 14, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced today that it will establish ...

  • PR Newswire

    111 to Announce Third Quarter 2019 Unaudited Financial Results on November 14, 2019

    SHANGHAI , Oct. 25, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform in China , today announced that ...

  • PR Newswire

    111 Unveils New Video on What the Internet Could Do for the Health Management of Aging

    SHANGHAI, Oct. 10, 2019 /PRNewswire/ -- 111, Inc. (YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced the release of the third episode in its 111 Insight series. The title announced today, What the Internet Could Do for the Health Management of Aging, is hosted by Mr. Junling Liu, Chairman and CEO of 111, Inc. Mr. Liu will moderate a discussion with Mr. Qingsheng Zhu, Managing Partner of 6 Dimensions Capital, and Mr. Qing Ye, Managing Director of GMP Pharmaceuticals Group. The 111 Insight series is produced by 111, Inc. and is hosted by Dr. Gang Yu, Co-Founder and Executive Chairman, and Mr. Junling Liu, Co-Founder, Chairman and CEO.

  • Small Caps Win in September: 5 Best ETFs & Stocks
    Zacks

    Small Caps Win in September: 5 Best ETFs & Stocks

    We highlight five small-cap ETFs and stocks that have outperformed in September. These could be excellent plays for investors should the same trends prevail.

  • PR Newswire

    Traditional Chinese Medicine Giant DEEJ Partners with 111 for Direct Sourcing

    SHANGHAI, Sept. 12, 2019 /PRNewswire/ -- 111, Inc. (YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced the signing of a strategic cooperation agreement with Dong-E-E-Jiao Co., Ltd. ("DEEJ") (000423.SZ), a leading company principally engaged in the research, development, production and sale of traditional Chinese medicines of Ejiao and Ejiao series products in China. DEEJ has selected 111 as its strategic omni-channel and direct sourcing partner, and will provide exclusive customized products to 111.

  • Estimating The Intrinsic Value Of 111, Inc. (NASDAQ:YI)
    Simply Wall St.

    Estimating The Intrinsic Value Of 111, Inc. (NASDAQ:YI)

    How far off is 111, Inc. (NASDAQ:YI) from its intrinsic value? Using the most recent financial data, we'll take a look...